Eugene Helsel
Consigliere Generale presso Artiva Biotherapeutics, Inc.
Profilo
Eugene Helsel is currently the Vice President of Regulatory Affairs & Quality at Artiva Biotherapeutics, Inc. Prior to this, he worked as the Senior Director of Regulatory Affairs at Capricor, Inc. and as the Executive Director of Regulatory Affairs & Quality at Fate Therapeutics, Inc. He received his undergraduate degree from National University and the University of California San Diego.
Posizioni attive di Eugene Helsel
| Società | Posizione | Inizio |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Consigliere Generale | - |
Precedenti posizioni note di Eugene Helsel
| Società | Posizione | Fine |
|---|---|---|
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Corporate Officer/Principal | - |
Formazione di Eugene Helsel
| University of California San Diego | Undergraduate Degree |
| National University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Borsa valori
- Insiders
- Eugene Helsel
